JMV-Journal de Medecine Vasculaire最新文献

Financial burden of lymphedema among breast cancer survivors in Iran: A qualitative study.

JMV-Journal de Medecine Vasculaire Pub Date : 2024-12-01 Epub Date: 2024-09-19 DOI: 10.1016/j.jdmv.2024.09.001

Hossein Yarmohammadi, Masood Soltanipur, Mohammad Shahrabi Farahani, Seyed Ehsan Hosseini, Zahra Sheikhi

{"title":"Financial burden of lymphedema among breast cancer survivors in Iran: A qualitative study.","authors":"Hossein Yarmohammadi, Masood Soltanipur, Mohammad Shahrabi Farahani, Seyed Ehsan Hosseini, Zahra Sheikhi","doi":"10.1016/j.jdmv.2024.09.001","DOIUrl":"https://doi.org/10.1016/j.jdmv.2024.09.001","url":null,"abstract":"Background: Breast cancer-related lymphedema (BCRL) is a chronic complication of breast cancer that requires long-term management. This condition imposes significant disturbance on breast cancer survivors (BCSs) physically, emotionally, and, financially. The purpose of this study was to approach the financial burden of BCRL in Iran.Methods: This qualitative study was performed based on the standards for reporting qualitative research (SRQR) guidelines. Semi-structured and in-depth interviews were conducted using a voice recorder. Data analysis was performed based on the content analysis method of Graneheim and Lundman. Nine women with BCRL participated in the study.Results: Three major themes were generated based on the captured data: (1) direct costs related to BCRL management, (2) indirect costs imposed by BCRL at work or home, and, (3) benefits of costs which was a great concern of BCSs that how much these costs eventually make their condition better. High costs of garments, lack of insurance coverage, and, difficulties in accessing lymphedema care were among the frequently mentioned problems by BCSs with BCRL.Conclusion: The financial burden of BCRL is significant on BCSs in Iran. The establishment of insurance coverage policies, easier access to health services, and, implanting patient-centered measures in evidence-based lymphedema guidelines, could be proper interventions to lower the financial burden of BCRL.","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 5-6","pages":"203-210"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Fenestration of the vertebral artery in a polytrauma patient: A vascular anatomical variant.

JMV-Journal de Medecine Vasculaire Pub Date : 2024-12-01 Epub Date: 2024-11-15 DOI: 10.1016/j.jdmv.2024.10.001

J-A Lebeul, A Petit, M-N De La Lance, J Potet

引用次数: 0

Endovascular treatment of persistent sciatic artery stenoses responsible for critical ischemia.

JMV-Journal de Medecine Vasculaire Pub Date : 2024-12-01 Epub Date: 2024-10-30 DOI: 10.1016/j.jdmv.2024.09.002

Vasile Nistor, Aymard Billong, Augustin Pirvu, Patrick Feugier

引用次数: 0

Reversible cerebral vasoconstriction syndrome following carotid artery revascularization: About three case reports and review of literature.

JMV-Journal de Medecine Vasculaire Pub Date : 2024-12-01 Epub Date: 2024-09-19 DOI: 10.1016/j.jdmv.2024.08.003

Pacôme Constant Dit Beaufils, Alderic Lecluse, Benoît Guillon, Godwin Tatah, Guillaume Marc

{"title":"Reversible cerebral vasoconstriction syndrome following carotid artery revascularization: About three case reports and review of literature.","authors":"Pacôme Constant Dit Beaufils, Alderic Lecluse, Benoît Guillon, Godwin Tatah, Guillaume Marc","doi":"10.1016/j.jdmv.2024.08.003","DOIUrl":"10.1016/j.jdmv.2024.08.003","url":null,"abstract":"Complication after carotid artery revascularization is mainly represented by stroke. Reversible cerebral vasoconstriction syndrome triggering by carotid artery revascularization is exceptional but it is an unrecognized aetiology of stroke. It could be associated with brain edema and henceforth, a posterior reversible encephalopathy syndrome can be confused with post-carotid artery revascularization cerebral hyperperfusion syndrome. We reported three cases about reversible cerebral vasoconstriction syndrome following revascularization therapy whose one had also a posterior reversible encephalopathy syndrome. This complication occurred within two weeks after carotid artery revascularization. All took nimodipine and all had a functional improvement at 3-months follow-up. Reversible cerebral vasoconstriction syndrome with posterior reversible encephalopathy syndrome after carotid artery revascularization may mimic cerebral hyperperfusion syndrome. After a comprehensive review, nineteen cases of reversible cerebral vasoconstriction syndrome post-carotid artery revascularization have been reported in the literature mainly after symptoms. It occurs mainly in women around sixty years of age. The onset is expected four days after revascularization.","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 5-6","pages":"195-202"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unresolved issues concerning venous thromboembolism. Venous thromboembolism in children. Consensus of the French Society of Vascular Medicine (SFMV).

JMV-Journal de Medecine Vasculaire Pub Date : 2024-12-01 Epub Date: 2024-11-20 DOI: 10.1016/j.jdmv.2024.11.001

Sophie Blaise, Gabrielle Sarlon, Marjolaine Talbot, Guillaume Mahé, Alessandra Bura-Rivière

{"title":"Unresolved issues concerning venous thromboembolism. Venous thromboembolism in children. Consensus of the French Society of Vascular Medicine (SFMV).","authors":"Sophie Blaise, Gabrielle Sarlon, Marjolaine Talbot, Guillaume Mahé, Alessandra Bura-Rivière","doi":"10.1016/j.jdmv.2024.11.001","DOIUrl":"10.1016/j.jdmv.2024.11.001","url":null,"abstract":"Venous thromboembolism (VTE) rarely occurs during childhood and, with few exceptions, should be considered as a disease of sick children. Current recommendations concerning the duration of anticoagulant treatment for paediatric VTE are essentially based on the results of clinical trials conducted in adults. Yet the underlying medical conditions, incidence, and anatomical locations of the disease, as well as the rates of unprovoked VTE, morbidity, and mortality, differ between adults and children. Unprovoked VTE is uncommon in childhood. Most children experiencing VTE present risk factors, such as the presence of a central venous catheter (CVC), cancer, chemotherapy (in particular with asparaginase or steroids), obesity, severe infection, congenital cardiopathy (notably in conjunction with hepatic venous stasis), serious trauma, an anatomical venous anomaly (such as atresia or agenesia) or a nephrotic syndrome (inducing a deficit in antithrombin or protein S), premature birth, or maternal combined oral contraception. The recent possibility of administering direct oral anticoagulants (DOAC) to children undoubtedly constitutes the greatest change in the treatment of paediatric VTE. The advantages of this therapy include the possibility of its oral administration, even in infants, the absence of any need for laboratory follow-up, and the lack of food interactions. With the approval of the direct factor Xa inhibitor rivaroxaban (by the European Medicines Agency and Health Canada), and the direct thrombin inhibitor dabigatran (by the European Medicines Agency and the US Food and Drug Administration), paediatric anticoagulant therapy is changing. Only rivaroxaban currently has a Marketing Authorisation in France for the treatment of childhood VTE.","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 5-6","pages":"211-218"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Management challenges of recurrent venous thromboembolism in advanced digestive cancers: Case studies and therapeutic strategies.

JMV-Journal de Medecine Vasculaire Pub Date : 2024-12-01 Epub Date: 2024-11-15 DOI: 10.1016/j.jdmv.2024.10.002

C Doutrelon, C Matray, C Klotz, S Delamarre, M Razafinimanana, F De Charry, J-M Cournac, C Jacquier, M Billhot, M Aletti

{"title":"Management challenges of recurrent venous thromboembolism in advanced digestive cancers: Case studies and therapeutic strategies.","authors":"C Doutrelon, C Matray, C Klotz, S Delamarre, M Razafinimanana, F De Charry, J-M Cournac, C Jacquier, M Billhot, M Aletti","doi":"10.1016/j.jdmv.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.jdmv.2024.10.002","url":null,"abstract":"Introduction: Venous thromboembolism (VTE) poses a significant challenge in cancer patients, particularly those with advanced malignancies. The management of recurrent VTE is complicated by the need for effective anticoagulation while addressing the underlying cancer progression.Cases: We present two clinical cases from the gastroenterology department at Percy French military hospital involving patients with progressive malignant digestive diseases. Patient 1, a 62-year-old woman, developed recurrent pulmonary embolism despite appropriate anticoagulation with low molecular weight heparin (LMWH). After treatment adjustments, she ultimately succumbed to tumor progression. Patient 2, a 54-year-old man hospitalized for pulmonary embolism, faced upper gastrointestinal bleeding and delayed anticoagulation initiation. Although he showed initial improvement with immunotherapy and stabilization of thrombotic events, he experienced oncological progression and recurrent VTE, leading to palliative care.Discussion: These cases illustrate the difficulties of managing recurrent VTE, even with curative anticoagulation and dose escalation. In case of VTE recurrence, it is essential to investigate for cancer progression and ensure patient adherence to treatment. A comprehensive management strategy should involve both the malignancy and the thrombotic complications.Conclusion: The management of recurrent VTE in cancer patients requires a multidisciplinary approach to evaluate the benefit-risk ratio of anticoagulation adjustments. These clinical cases highlight the necessity for integrated care that addresses both oncological and thrombotic concerns, emphasizing the importance of timely intervention and collaboration among healthcare providers.","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 5-6","pages":"222-227"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142796393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unresolved questions on venous thromboembolic disease. Venous thromboembolism (VTE) management in obese patients. Consensus statement of the French Society of Vascular Medicine (SFMV) 静脉血栓栓塞性疾病的未决问题。肥胖患者的静脉血栓栓塞症（VTE）治疗。法国血管医学会（SFMV）共识声明

JMV-Journal de Medecine Vasculaire Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.08.001

Sébastien Miranda , Marjolaine Talbot , Isabelle Gouin-Thibault , Benjamin Espinasse , Guillaume Mahe , SFMV

引用次数: 0

Impact on healing of double-layered compression stocking in the treatment of severe venous leg ulcers: A prospective, multicenter, controlled trial 双层压力袜治疗严重静脉性腿部溃疡对愈合的影响：前瞻性多中心对照试验

JMV-Journal de Medecine Vasculaire Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.07.001

Audrey Stansal , Angelique Marchand , Isabelle Lazareth , Ulrique Michon-Pasturel , Alexandra Yannoutsos , Candice Ostrowka , Clémence Berthin , Tiffany Klejtman , Nina Sigg , Clément Jaillette , Florence Perrinet , Raphaël Attal , Soufyane Sebbane , Mathilde Pecourt , Parinaz Ghaffari , Clémence Caucanas , Emmanuelle Sacco , Hélène Beaussier , Pascal Priollet

{"title":"Impact on healing of double-layered compression stocking in the treatment of severe venous leg ulcers: A prospective, multicenter, controlled trial","authors":"Audrey Stansal , Angelique Marchand , Isabelle Lazareth , Ulrique Michon-Pasturel , Alexandra Yannoutsos , Candice Ostrowka , Clémence Berthin , Tiffany Klejtman , Nina Sigg , Clément Jaillette , Florence Perrinet , Raphaël Attal , Soufyane Sebbane , Mathilde Pecourt , Parinaz Ghaffari , Clémence Caucanas , Emmanuelle Sacco , Hélène Beaussier , Pascal Priollet","doi":"10.1016/j.jdmv.2024.07.001","DOIUrl":"10.1016/j.jdmv.2024.07.001","url":null,"abstract":"<div>Venous leg ulcer refers to chronic wounds, generally difficult to heal and often prone to recurrence. The objective of this research was to assess a double layered compression stocking VenoTrain® ulcertec on a population with mostly severe pathologies. This prospective, multicenter, interventional type II study was conducted between September 2018 and January 2022. Out of 124 patients enrolled, 97.6% had a history of previous leg ulceration, 72.6% were already being followed for leg ulcerations, 30.9% were severely overweight and 24.2% diabetic. Overall, a majority of target ulcers were present for 6months or more, and the ulcer surface area was larger than 8cm2 in nearly one in every five cases. The primary endpoint was the rate of closed ulcer after a maximum follow-up of 20weeks. While most of the treated venous leg ulcerations may be regarded as hard-to-heal wounds, closure rate at 20weeks ranged between 50.0% (two severity criteria) and 69.0% (no severity criteria) according to baseline wound severity criteria. Besides, VenoTrain® ulcertec device was particularly well accepted and tolerated by patients. In 93.2% of visits, patients stated using it every day. When managing venous ulcerations not requiring strongly thick absorbent dressings, VenoTrain® ulcertec device represents an efficient and more suitable alternative to venous compression bandaging.</div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 123-134"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2542451324001330/pdfft?md5=9480918d81db129f2e57cb1287772827&pid=1-s2.0-S2542451324001330-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141848470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Bilateral dolichoarteriopathy of internal carotid arteries as cause of bilateral ischemic strokes: Case report 导致双侧缺血性脑卒中的双侧颈内动脉胆脂瘤病：病例报告

JMV-Journal de Medecine Vasculaire Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.05.001

O. Lahjouji, A. Akammar, N. El Bouardi, M. Haloua, B. Alami, M. Boubbou, S. Bouchal, N. Chtaou, F. Belahsen, M. Maaroufi, M.Y. Alaoui Lamrani

{"title":"Bilateral dolichoarteriopathy of internal carotid arteries as cause of bilateral ischemic strokes: Case report","authors":"O. Lahjouji, A. Akammar, N. El Bouardi, M. Haloua, B. Alami, M. Boubbou, S. Bouchal, N. Chtaou, F. Belahsen, M. Maaroufi, M.Y. Alaoui Lamrani","doi":"10.1016/j.jdmv.2024.05.001","DOIUrl":"10.1016/j.jdmv.2024.05.001","url":null,"abstract":"<div>Most anatomic features of the internal carotid artery (ICA) are described as a straight course to the skull base free of branches. In some cases, the excessive elongation of the internal carotid artery in a confined space results in a curvature showing a “C” or “S” shape, or in an abnormal vascular shape made of a single or double vessel loop. These anatomic variants are called dolichoarteriopathies of the internal carotid artery. The correlation between dolichoarteriopathy of the ICA and stroke is still questionable, however it is believed that it can be associated with cerebral ischemia with a clinical symptomatology that accompanies ischemic stroke. We report a case of a 41-year-old patient, with a history of hypertension, who was admitted for right hemiparesis with Broca's aphasia. The rest of the clinical examination was normal. Radiological investigations confirmed an acute left sylvian ischemic stroke with an abrupt occlusion of the posterior trunk of the left M2 segment on the CT angiogram, an excessive elongation of the ICA on both sides, describing a shape of coils or loops. Etiologic workup for ischemic stroke was negative.</div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 186-189"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142228950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Update on the diagnosis of recurrence of lower limb deep vein thrombosis. A Consensus statement of the French Society for Vascular Medicine (SFMV) 下肢深静脉血栓复发诊断的最新进展。法国血管医学会（SFMV）共识声明

JMV-Journal de Medecine Vasculaire Pub Date : 2024-09-01 DOI: 10.1016/j.jdmv.2024.08.002

Antoine Elias , Mario Maufus , Marie Elias , Marjolaine Talbot , Guillaume Mahe , Marie-Antoinette Sevestre , Gilles Pernod , French Society for Vascular Medicine (SFMV)

{"title":"Update on the diagnosis of recurrence of lower limb deep vein thrombosis. A Consensus statement of the French Society for Vascular Medicine (SFMV)","authors":"Antoine Elias , Mario Maufus , Marie Elias , Marjolaine Talbot , Guillaume Mahe , Marie-Antoinette Sevestre , Gilles Pernod , French Society for Vascular Medicine (SFMV)","doi":"10.1016/j.jdmv.2024.08.002","DOIUrl":"10.1016/j.jdmv.2024.08.002","url":null,"abstract":"<div>An accurate diagnosis of lower limb deep vein thrombosis (DVT) recurrence is mandatory. The diagnosis is difficult and has not been well investigated. Our objective was to define the role of clinical probability assessment, D-dimer assay, venous ultrasound and other imaging methods in the diagnosis of this condition based on a review of published data. Our review did not find any clinical prediction rule (CPR) specific to the diagnosis of DVT recurrence. D-dimer assays have not been sufficiently validated or proved effective either alone or when combined with the assessment of clinical probability or with ultrasound. The only validated ultrasound criteria are a new non-compressible vein segment and a≥2mm or>4mm increase in diameter of the common femoral or popliteal vein under compression in the transverse plane between two examinations. Limitations of these criteria include poor inter-observer agreement, non-availability of previous ultrasound reports and measurements, a high percentage of non-diagnostic ultrasound results, lack of power in diagnostic accuracy and diagnostic management studies, and lack of external validation. The analysis of venous obstruction, thrombus appearance, vein diameter and blood flow based on colour Doppler ultrasound criteria has not yet been validated in studies. Magnetic resonance direct thrombus imaging (MRDTI) is a new promising diagnostic imaging method, but is hardly accessible, costly and needs large scale validation studies. Based on this review, an update of the guidance for clinical practice is proposed for the diagnostic management of patients with clinically suspected lower limb DVT recurrence.</div>","PeriodicalId":53149,"journal":{"name":"JMV-Journal de Medecine Vasculaire","volume":"49 3","pages":"Pages 176-185"},"PeriodicalIF":0.0,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142228947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0